ACROBiosystems
ACROBiosystems is a publicly traded biotechnology tools company that manufactures recombinant proteins, antibodies, cell lines, and GMP-grade raw materials for biopharmaceutical drug discovery and cell and gene therapy manufacturing, serving global pharmaceutical companies and biotech firms across 30+ countries.
- Company typePublic
- Founded2010
- HeadquartersNewark, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What ACROBiosystems does
ACROBiosystems is a publicly traded (SZSE: 301080) biotechnology tools company founded in 2010 that manufactures recombinant proteins, antibodies, cell lines, ELISA kits, and GMP-grade raw materials primarily for biopharmaceutical drug discovery and cell and gene therapy (CGT) manufacturing. The company's product portfolio spans eight branded sub-lines — ActiveMax (cell activation beads), CelThera (serum-free media), GENIUS (nucleases), GENPower (CRISPR-Cas enzymes), resDetect (residual detection), SAFENSURE (safety testing), Star Staining (fluorescent labeling), and Aneuro (neuroscience proteins) — covering the full research-to-clinical workflow for CAR-T, CAR-NK, TCR-T, ADC, gene therapy, and iPSC applications. Manufacturing is anchored at a 50,000+ square meter GMP facility in Suzhou, China (operational since June 2024) with ISO 9001, GMP, Rx-360, MDSAP, and ADR certifications, complemented by regional headquarters in Newark, Delaware (North America) and Zug, Switzerland (Europe), with offices across 15 cities and distribution in 30+ countries.
The company's revenue model combines one-time catalog sales of research-use reagents with quote-based pricing for custom GMP-grade proteins and cell therapy raw materials, plus licensing (notably HEK293 functional cell lines) and fee-for-service analytical testing. Go-to-market is sales-led, leveraging direct enterprise relationships with global pharmaceutical companies (Pfizer, Novartis, Johnson & Johnson, Roche, AstraZeneca, AbbVie, Takeda, Boehringer Ingelheim), regional sales teams in the US, Europe, and Asia-Pacific, and distribution partnerships with Fisher Scientific and VWR. The company is investing in AI-driven protein engineering via the proprietary Acro-AIx system, which has demonstrated a 20-fold increase in protein expression yield, and recently secured PMDA Material Suitability Confirmation for GMP-grade IL-15 in Japan, signaling international regulatory expansion.
ACROBiosystems firmographics
Firmographics- Name
- ACROBiosystems
- Legal name
- ACROBiosystems
- Website
- https://acrobiosystems.com
- Company type
- Public
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- ACROBiosystems is a publicly traded biotechnology tools company that manufactures recombinant proteins, antibodies, cell lines, and GMP-grade raw materials for biopharmaceutical drug discovery and cell and gene therapy manufacturing, serving global pharmaceutical companies and biotech firms across 30+ countries.
- Ownership category
- akta.pro rank
ACROBiosystems industry classification
Industry- Product category
- Biopharmaceutical Reagents
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)
- akta.pro secondary industries
- Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)
Keywords
Where ACROBiosystems is headquartered
LocationHeadquarters
- HQ city
- Newark
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
ACROBiosystems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
Revenue model
- Recombinant Protein Sales: Sale of recombinant proteins including cytokines, growth factors, enzymes, immune checkpoints, and GMP-grade materials for biopharmaceutical research and cell therapy manufacturing.
- Antibody Products: Sale of antibodies including immunohistochemistry antibodies, anti-idiotype antibodies, anti-payload antibodies, and isotype controls.
- Cell Lines: Sale of functional cell lines including reporter cell lines, overexpression cell lines, and knockout cell lines. Global commercial license assistance provided for regulatory filings.
- Kits and Assay Reagents: ELISA kits, qPCR kits, fluorescence assay kits, flow cytometry kits, and ADC conjugation kits for drug discovery and quality control.
- Cell Culture Reagents: GMP-grade growth factors, extracellular matrix proteins, serum-free cell culture media, magnetic beads, and nucleases for cell therapy manufacturing.
- Custom Development Services: Custom GMP-grade protein services, cell line customization, MHC complex services, ELISA services, SPR/BLI analytical services, and TR-FRET kit development.
- Analytical Testing Services: SAFENSURE safety testing services including endotoxin testing, mycoplasma qPCR testing, sterility testing, and quality characterization services.
- Licensing Solutions: HEK293 functional cell line licensing with purchase-based authorization model embedding IP clearance into procurement, with exclusions for Greater China region.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Gene Knockout Cell Lines - SCRAJ-STT227 (Raji/Human CD20 Knockout Stable Cell Line) |
| Other | Monthly | Standard terms for product sales |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
ACROBiosystems product offering
Product offeringCore offering
ACROBiosystems manufactures and sells recombinant proteins, antibodies, cell lines, kits, and GMP-grade raw materials for biopharmaceutical research, antibody drug development, and cell and gene therapy applications. The company supplies critical reagents and quality raw materials used by biopharmaceutical companies in drug discovery, development, and manufacturing workflows.
Product overview
ACROBiosystems is a biotechnology company founded in 2010 offering a comprehensive portfolio of recombinant proteins, antibodies, cell lines, kits, and GMP-grade reagents for biopharmaceutical research and cell and gene therapy development. The product ecosystem centers on core reagent categories (Recombinant Proteins, Antibodies, Cell Lines, ELISA Kits, Viral Antigens) supported by specialized sub-brands including ActiveMax (magnetic cell activation beads), CelThera (cell expansion media), GENIUS Nuclease (residual nucleic acid removal), GENPower (CRISPR-Cas enzymes), SAFENSURE (safety testing), resDetect (residual detection kits), and Star Staining (fluorescent labeling). The company provides end-to-end solutions from research through clinical manufacturing, with GMP-grade capabilities at its Suzhou facility for cell and gene therapy raw material supply.
Differentiator
Problem solved
Functional benefit
Brands
- ActiveMax: Brand for cell culture grade magnetic beads including CD3/CD28 beads, CD19 beads, BCMA beads, and DLL4 beads.
- Aneuro
- CelThera
- CytoPak
- GENIUS
- GENPower
- Resilient Supply
- resDetect
- SAFENSURE
- Star Staining
- Star Ribbon
Products and services
- Recombinant Proteins Recombinant proteins manufactured for biopharmaceutical research and drug development applications, used by pharma and biotech companies.
- Antibodies Antibodies supplied for biopharmaceutical research and therapeutic development workflows.
- Cell Lines Cell lines developed for biopharmaceutical research and cell therapy applications.
- Kits Assay and reagent kits for biopharmaceutical research and drug development applications.
- GMP-Grade Raw Materials GMP-compliant raw materials for cell and gene therapy manufacturing and antibody drug conjugate production, used by biopharmaceutical manufacturers.
Quantifiable outcome
- 20-fold increase in expression yield through AI-powered protein engineering
- +3 more outcomes
Companies that use ACROBiosystems
Customer profileNamed customers14 records
Segments7 records
Ideal customer profiles1 record
ACROBiosystems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature8 records
ACROBiosystems partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered minor, major and core.
- Fisher ScientificminorDistribution partner listing ACROBiosystems cell line products including CD20 knockout cell line on fisher scientific website.
- VWRminorDistribution partner listing ACROBiosystems products through VWR website search functionality.
- Roche/GenentechmajorRoche/Genentech executives participate in BIOSeedin partnering summits where licensing trends, M&A opportunities, and innovation strategies are discussed. Part of ongoing strategic dialogue.
- AstraZenecamajorAstraZeneca participates in panel discussions at BIOSeedin summits exploring oncology and autoimmune innovation strategies with Chinese biotech partners.
- TakedamajorTakeda participates as panel executives at BIOSeedin Summer Summit discussing global licensing and innovation strategies.
- Boehringer IngelheimmajorExecutive representation at BIOSeedin partnering summit exploring global innovation and licensing opportunities.
- Daiichi SankyomajorDaiichi Sankyo executives participate in panel discussions at partnering summit focused on late-stage clinical pipelines and licensing transactions.
- Otsuka PharmaceuticalminorExecutive participation at partnering summit representing Japanese pharmaceutical industry perspectives.
- Sun PharmaminorIndian pharmaceutical company representation at partnering summit discussing licensing and M&A trends.
- ServierminorFrench pharmaceutical company participation in partnering summit discussions.
- PfizercorePfizer is identified as a strategic partner in drug discovery and development. ACROBiosystems provides global licensing solutions and protein products to support Pfizer's biopharmaceutical R&D operations.
- NovartiscoreNovartis partners with ACROBiosystems utilizing the global licensing solution for HEK293 functional cell lines. The partnership supports Novartis' internal research and drug discovery programs.
- Johnson & JohnsoncoreJohnson & Johnson is identified as a strategic partner. ACROBiosystems supports J&J's biopharmaceutical innovation through product supply and partnership summits.
- AbbViemajorAbbVie executives participate in bioSeedin JPM Spotlight discussions on oncology, cardio-renal-metabolic, and autoimmunity therapeutic areas.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
ACROBiosystems competitors and assessment
Company assessmentDirect peers
- Bio-Techne: Bio-Techne is a leading US-based supplier of recombinant proteins, antibodies, and reagents for life science research and bioprocessing. It directly competes with ACROBiosystems across recombinant proteins, GMP cytokines, and cell therapy reagents, with a much larger catalog and broader distribution.
- Sino Biological: Sino Biological is a Chinese-headquartered recombinant protein and antibody manufacturer with a catalog comparable to ACROBiosystems, including cytokines, growth factors, and viral antigens. It is a direct competitor especially across research-grade reagents and increasingly in GMP-grade offerings for CGT developers.
- Miltenyi Biotec: Miltenyi Biotec provides GMP-grade reagents, cell activation beads (similar to ActiveMax), and cell therapy manufacturing solutions. Its MACS GMP portfolio and CliniMACS platform compete directly with ACROBiosystems' cell therapy raw materials and HEK293-based offerings.
- GenScript: GenScript is a global biotechnology tools company offering recombinant proteins, gene synthesis, peptide services, and cell therapy reagents. Its Life Science research reagents business directly overlaps with ACROBiosystems' core recombinant protein and antibody catalog.
Broad incumbents
- Cytiva: Cytiva (a Danaher company) is a broad incumbent in bioprocessing and cell/gene therapy manufacturing, offering consumables, reagents, and instrumentation that overlap with ACROBiosystems' GMP raw materials and process reagents. While much larger and broader, Cytiva competes for the same CGT manufacturing wallet.
- Lonza: Lonza is a major CDMO and bioprocessing supplier with GMP-grade raw materials and cell therapy manufacturing services. While primarily a CDMO, Lonza competes with ACROBiosystems in supplying GMP-grade cytokines and cell therapy process materials to large pharma customers.
- PeproTech (Thermo Fisher Scientific): PeproTech, now part of Thermo Fisher Scientific, is one of the original recombinant cytokine and growth factor suppliers. Following integration into Thermo Fisher's life sciences portfolio, PeproTech products directly compete with ACROBiosystems' recombinant protein and GMP cytokine offerings at research and process scale.
- Abcam (Danaher): Abcam, now part of Danaher, is a leading global supplier of research-grade antibodies and reagents. While more focused on antibodies than ACROBiosystems' full portfolio, Abcam directly overlaps in IHC antibodies, anti-idiotype antibodies, and recombinant antibody tools for pharma R&D.
Emerging players
- CellGenix: CellGenix is a Germany-headquartered supplier of GMP-grade raw materials for cell and gene therapy, including cytokines, growth factors, and cell culture media. It is a focused direct peer to ACROBiosystems' GMP raw materials portfolio serving CAR-T and TCR-T developers in Western markets.
- Novoprotein Scientific: Novoprotein is a Chinese recombinant protein manufacturer offering cytokines, growth factors, and custom protein services at competitive price points. It is an emerging direct peer competing with ACROBiosystems in research-grade recombinant proteins globally and in GMP-grade offerings for the Chinese CGT market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
ACROBiosystems social profiles
Digital presenceACROBiosystems compliance and trust
Trust signalCompliance6 records
ACROBiosystems financial estimates
Financial estimateRevenue estimate
Valuation estimate
ACROBiosystems leadership team
Management profileNumber of profiles
ACROBiosystems funding detail
Funding detailFunding overview
Funding rounds3 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ACROBiosystems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ACROBiosystems
What does ACROBiosystems do?
ACROBiosystems manufactures and sells recombinant proteins, antibodies, cell lines, kits, and GMP-grade raw materials for biopharmaceutical research, antibody drug development, and cell and gene therapy applications. The company supplies critical reagents and quality raw materials used by biopharmaceutical companies in drug discovery, development, and manufacturing workflows.
Is ACROBiosystems a public or private company?
ACROBiosystems is a public company. It is classified as public and is currently operating.
When was ACROBiosystems founded?
ACROBiosystems was founded in 2010. It employs 251 to 500 people.
Where is ACROBiosystems based?
ACROBiosystems is headquartered in Newark, United States, in the North America region.
How does ACROBiosystems make money?
Eight revenue lines are on record. Recombinant Protein Sales are the primary driver. The others are antibody Products, cell Lines, kits and Assay Reagents, cell Culture Reagents, custom Development Services, analytical Testing Services and licensing Solutions.
Who are ACROBiosystems's main competitors?
Direct peers on record are Bio-Techne, Sino Biological, Miltenyi Biotec and GenScript. Broad incumbents are Cytiva, Lonza, PeproTech (Thermo Fisher Scientific) and Abcam (Danaher). Emerging players are CellGenix and Novoprotein Scientific.
Does ACROBiosystems have an API?
No public API is recorded for ACROBiosystems.
What industry is ACROBiosystems in?
ACROBiosystems's product category is Biopharmaceutical Reagents. Its primary akta.pro industry code is HLAGAGAI, Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines), with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 325414 and its SIC code is 2836.